Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting

NEXT STORY
Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting
PREV STORY
Cidara Provides Corporate Update and Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Recce Pharmaceuticals Enters Agreement with Path BioAnalytics to Test RECCE® Compounds in Expanded SARS-CoV-2 Program

author_avatar
NASDAQ Market News

ContraFect Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Selecta Biosciences Announces First Patient Dosed in Phase 1 Trial of SVP-Rapamycin and LMB-100 Combination Therapy in Mesothelioma

WATERTOWN, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News